Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 14, 2022

Investigational Drug Information for Nepadutant

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug Nepadutant?

Nepadutant is an investigational drug.

There have been 4 clinical trials for Nepadutant. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1^st 2010.

The most common disease conditions in clinical trials are Colic, Digestive System Diseases, and Gastrointestinal Diseases. The leading clinical trial sponsors are Menarini Group and [disabled in preview].

Summary for Nepadutant

US Patents	0
International Patents	0
US Patent Applications	10
WIPO Patent Applications	4
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2010-11-01)
Vendors	6

Recent Clinical Trials for Nepadutant

Title	Sponsor	Phase
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance	Menarini Group	Phase 2
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment	Menarini Group	Phase 2
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic	Menarini Group	Phase 2

See all Nepadutant clinical trials

Clinical Trial Summary for Nepadutant

Top disease conditions for Nepadutant

Top clinical trial sponsors for Nepadutant

See all Nepadutant clinical trials

US Patents for Nepadutant

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Boehringer Ingelheim

Colorcon

AstraZeneca

Harvard Business School

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.